Clinical effectiveness of first-line chemoradiation for adult patients with locally advanced non-small cell lung cancer: a systematic review

被引:31
|
作者
Brown, T. [1 ]
Pilkington, G. [1 ]
Boland, A. [1 ]
Oyee, J. [1 ]
Smith, C. Tudur [2 ]
Dundar, Y. [1 ]
Richards, E. [3 ]
Yang, R. [4 ]
Dickson, R. [1 ]
机构
[1] Univ Liverpool, Liverpool Reviews & Implementat Grp, Liverpool L69 3BX, Merseyside, England
[2] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England
[3] Clatterbridge Ctr Oncol, Wirral, Merseyside, England
[4] Peking Univ, Inst Populat Res, Beijing 100871, Peoples R China
关键词
QUALITY-OF-LIFE; RANDOMIZED PHASE-II; LEUKEMIA GROUP-B; STAGE-III; CONCOMITANT CHEMORADIOTHERAPY; SEQUENTIAL CHEMORADIOTHERAPY; WEEKLY PACLITAXEL; TRIAL; CHEMOTHERAPY; CISPLATIN;
D O I
10.3310/hta17060
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Lung cancer is the most common cancer in the world and the second most common cancer diagnosed in the UK after breast cancer. In 2008, there were 40,806 new cases of lung cancer diagnosed in the UK, with 32,546 in England and 2403 in Wales.(1) Lung cancer is rarely diagnosed in people <40 years of age, and 86% of cases occur in people >60 years.(1) Table 1 provides an overview of lung cancer statistics in the UK. The European age-standardised incidence rate of lung cancer in 2008 was 45.6 per 100,000 population in England and 52.2 per 100,000 population in Wales.(1) The UK incidence rate in men is similar to incidence rates in most of Western Europe and is lower than incidence rates in most of Eastern Europe. 1 The UK incidence rate in women is one of the highest rates in the European Union.(1) There is an increased incidence of lung cancer in individuals from the lowest socioeconomic strata.(2) In 2008, around 65,000 individuals were living with lung cancer in the UK; 1 the majority of these individuals were men.(1)
引用
收藏
页码:1 / +
页数:101
相关论文
共 50 条
  • [31] Clinical Study of Pemetrexed as the First-line Treatment in Elderly Patients with Advanced Non-squamous Non-small Cell Lung Cancer
    Pu Xiaolin
    Wang Jun
    Li Wei
    Lu Binbin
    Wang Zhaoxia
    Yang Min
    Fan Weifei
    JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2013, 1 (04): : 205 - 209
  • [32] Erlotinib in routine clinical practice for first-line maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC)
    Faehling, M.
    Achenbach, J.
    Staib, P.
    Steffen, U.
    Tessen, H. W.
    Gaillard, V. E.
    Brugger, W.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (07) : 1375 - 1383
  • [33] Advances and challenges of first-line immunotherapy for non-small cell lung cancer: A review
    Guo, Haiyang
    Zhang, Jun
    Qin, Chao
    Yan, Hang
    Luo, Xinyue
    Zhou, Haining
    MEDICINE, 2024, 103 (03) : E36861
  • [34] The cost-effectiveness of cemiplimab plus chemotherapy as the first-line treatment for advanced non-small cell lung cancer
    Lu, Tingting
    Huang, Yufan
    Cai, Zhongjie
    Lin, Wangchun
    Chen, Xiaoxiao
    Chen, Ruijia
    Hu, Yingying
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [35] Cost-Effectiveness of the Addition of Bevacizumab to First-Line Chemotherapy With Carboplatin and Paclitaxel in Patients With Non-Small Cell Lung Cancer
    Parody-Rua, Elizabeth
    Augusto Guevara-Cuellar, Cesar
    VALUE IN HEALTH REGIONAL ISSUES, 2020, 23 : 93 - 98
  • [36] Cost-effectiveness of Osimertinib in the First-Line Treatment of Patients With EGFR-Mutated Advanced Non-Small Cell Lung Cancer
    Aguiar, Pedro N., Jr.
    Haaland, Benjamin
    Park, Wungki
    Tan, Pui San
    del Giglio, Auro
    Lopes, Gilberto de Lima, Jr.
    JAMA ONCOLOGY, 2018, 4 (08) : 1080 - 1084
  • [37] First-Line Gefitinib Treatment for Patients with Advanced Non-small Cell Lung Cancer with Poor Performance Status
    Lee, Young Joo
    Kim, Heung Tae
    Han, Ji-Youn
    Yun, Tak
    Lee, Geon Kook
    Kim, Hyae Young
    Sung, Ji-Hyun
    Lee, Jin Soo
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (03) : 361 - 368
  • [38] The Role of Immunotherapy in the First-Line Treatment of Elderly Advanced Non-Small Cell Lung Cancer
    Spagnuolo, Alessia
    Gridelli, Cesare
    CANCERS, 2023, 15 (08)
  • [39] Patterns and predictors of first-line chemotherapy use among adults with advanced non-small cell lung cancer in the cancer research network
    Ritzwoller, Debra P.
    Carroll, Nikki M.
    Delate, Thomas
    Hornbrook, Mark C.
    Kushi, Lawrence
    Bowles, Erin J. Aiello
    Freml, Jared M.
    Huang, Karl
    Loggers, Elizabeth T.
    LUNG CANCER, 2012, 78 (03) : 245 - 252
  • [40] Nutritional status changes in patients with advanced non-small cell lung cancer receiving first-line chemotherapy
    Wei Sun
    Shunfang Liu
    Ping Peng
    Dongbo Liu
    OncologyandTranslationalMedicine, 2018, 4 (02) : 54 - 57